Divi's Laboratories

Divi's Laboratories

DIVISLAB

 ₹ 6,033.95
 ₹ 27.99
0.47%
Healthcare
 ₹ 0.00
(%)1D
Updated: 06 Dec 2024, 03:31:16 pm IST
Stock Score
Open Price
 ₹ 5,979.63
Prev. Close
 ₹ 6,005.96
 ₹ 5,772.38
Day Low
 ₹ 6,096.83
Day High

 ₹ 3,205.23
52 Week Low
 ₹ 6,197.93
52 Week High

Quick Bite

Price To Earnings Ratio

99.93

Sector PE

71.67

PB Ratio

11.78

Sector PB

9.22

EPS

60.38

Dividend Yield

0.87

Today's Volume

558.728 K

5 Day Avg. Volume

807.321 K

PEG Ratio

-8.14

Market Cap.

₹ 1,60,000.00 Cr.

Returns Comparison

TimeDIVISLABVSIndustry
1 Day0.28%-1.57%
1 Week-0.57%-0.71%
1 Month5.92%-0.68%
6 Months28.25%19.22%
1 Year60.31%40.44%

StockGro Trade Views 👍

StockGro Trade Views 👍

Technical Trend

Bullish
academy home
Bearish
Neutral
Bullish

Pivot Levels

R3 ₹ 6,166.27
R2 ₹ 6,131.55
R1 ₹ 6,077.28
RESISTANCE
 ₹ 6,042.56
SUPPORT
S1 ₹ 5,988.29
S2 ₹ 5,953.57
S3 ₹ 5,899.30

Updated: 22 Jul 2024,09:18:33 am IST

Moving Averages

Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
1
Buy
5
Period (Days)SMAIndication
106037.27Bearish
205909.02Bullish
305861.22Bullish
505784.29Bullish
1005380.09Bullish
2004696.93Bullish

Updated: 06 Dec 2024, 03:14:57 pm IST

Analyst Rankings 👍

Analyst Rankings 👍

Shareholding Updates

PromotersDIIFIIPublicOthers
51.89%
Promoters
Sep 2024
Promoters  51.89%
FII  17.25%
DII  21.06%
Public  9.8%
Others  0%

Mutual Fund Ownership 👍

Mutual Fund Ownership 👍

Cash Flow

AnnualFY 2024FY 2023FY 2022
Operating Activities1261.002459.001911.80
Investing Activities-269.00-2707.00-2194.92
Financing Activities-799.00-797.00-532.44
Net Cash Flow193.00-1045.00-815.56

All Figures in ₹ Cr., unless mentioned otherwise

Ratios

Return on Equity (%)

Income Statement

All Figures in ₹ Cr., unless mentioned otherwise

Balance Sheet

All Figures in ₹ Cr., unless mentioned otherwise

Peer Comparison

Name1D (%)1W (%)1M (%)6M (%)1Y (%)
Divi's Laboratories0.28-0.575.9228.2560.31
Alembic-0.874.081.292.512.51
Aurobindo Pharma1.41-0.57-10.08-10.8414.22
Fortis Healthcare2.647.7217.1247.1878.55
Ajanta Pharmaceuticals-1.34-5.51-8.7112.4738.64
Returns as on 06 Dec, 2024

About Divi's Laboratories

Divi's Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl, Vigabatrin, and others. The Company is also engaged in custom synthesis (contract manufacturing services) of APIs and Intermediates for global innovator companies with a portfolio of products across diverse therapeutic areas. The Company's subsidiaries include Divis Laboratories (USA) Inc. and Divi's Laboratories Europe AG.

Divi's Laboratories Share Price

Divi's Laboratories Limited is an Indian company that manufactures and markets active ingredients (APIs), intermediates and nutrients for export. The company's products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to its generic business, the Company supports pharmaceutical companies through custom synthesis businesses in the commercialization of their proprietary products, from gram-scale requirements for clinical trials to launch and late life cycle management. The company's subsidiaries are Divis Laboratories (USA) Inc and Divi's Laboratories Europe AG.

Divi's Laboratories FAQs

How to Buy Divi's Laboratories Share?

up
To purchase Divi's Laboratories shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Divi's Laboratories (ticker symbol: DIVISLAB) on the trading platform provided by your broker and purchase the shares.

What's Divi's Laboratories share price today?

up
The stock price of Divi's Laboratories as of 06 Dec 2024 is ₹6,033.95

What is the Market Cap of Divi's Laboratories?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 06 Dec 2024, Divi's Laboratories (ticker symbol: DIVISLAB) has a market capitalisation of approximately ₹16,00,00,00,00,000.00

What is the PE and PB ratio of Divi's Laboratories?

up
Divi's Laboratories Ltd's price-to-book ratio as of 06 Dec 2024 is 11.78, reflecting the market's valuation compared to its asset value. As of 06 Dec 2024, the trailing twelve months P/E (price-to-earnings) ratio is 99.93, indicating the market values the company at around ₹99.93 for every ₹1 of earnings

What is the 52 Week High and Low of Divi's Laboratories Share?

up
Divi's Laboratories Ltd (DIVISLAB) hit its 52-week high at ₹6,197.93, and its 52-week low at ₹3,205.23.
Want to learn and earn in Stocks?
Login/Register
Start Learning